加科思-B:早盘涨 3.30% 开展三期试验

和讯网
09 May

【加科思-B 早盘股价上涨 3.30%,现报 3.76 港元,成交额 861.64 港元】加科思-B 发布公告,其自主研发的 SHP2 抑制剂 sitneprotafib 相关研究见刊 Clinical Cancer Research。文章公布了该抑制剂与 PD-1 抗体以及靶向 RTK/RAS/MAPK 通路联合疗法的临床前体内外数据和代表性患者病例。研究表明 sitneprotafib 显著...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10